Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• HuangTLChienCYTsaiWLLong-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapyHead Neck201638Suppl 1E1026E103226041548
   PubMedGoogle Scholar
• SuSFHanFZhaoCLong-term outcome of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyChin J Cancer Prev Treat20132011853858
   Google Scholar
• TuBJClinical studies of Montezuma combined with cisplatin and three-dimensional conformal radiotherapy chemotherapy in the treatment of nasopharyngeal carcinomaGuangzhou University2013 Available from: http://d.g.wanfangdata.com.cn/Thesis_D375768.aspxAccessed November 1, 2017
   Google Scholar
• Ou YangPYXieCMaoYPSignificant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trialsAnn Oncol20132482136214623613477
   PubMedGoogle Scholar
• LeeAWTungSYChuaDTRandomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst2010102151188119820634482
   PubMed Web of Science ®Google Scholar
• ChanATLeungSFNganRKOverall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst200597753653915812080
   PubMed Web of Science ®Google Scholar
• BrowmanGPHodsonDIMackenzieRJBesticNZurawLCancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site GroupChoosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysisHead Neck200123757958911400247
   PubMed Web of Science ®Google Scholar
• ZhangZCFuSWangFWangHYZengYXShaoJYOncogene mutational profile in nasopharyngeal carcinomaOnco Targets Ther2014745746724672248
   PubMed Web of Science ®Google Scholar
• MaBBPoonTCToKFPrognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma – a prospective studyHead Neck2003251086487212966511
   PubMed Web of Science ®Google Scholar
• ChuaDTNichollsJMShamJSAuGKPrognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapyInt J Radiat Oncol Biol Phys20045911120
   PubMedGoogle Scholar
• VallathSHyndsRESucconyLJanesSMGiangrecoATargeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunitiesEur Respir J201444251352224435005
   PubMedGoogle Scholar
• NicholasMKLukasRVChmuraSYaminiBLesniakMPytelPMolecular heterogeneity in glioblastoma: therapeutic opportunities and challengesSemin Oncol201138224325321421114
   PubMed Web of Science ®Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed December 10, 2015
   Google Scholar
• HigginsJPAltmanDGGøtzschePCCochrane Bias Methods GroupCochrane Statistical Methods GroupThe Cochrane Collaboration’s tool for assessing risk of bias in randomized trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• SongFGilbodySBias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysisBMJ19983167129471
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• LiZZhouQLiYFuJHuangXShenLGrowth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: a meta-analysisOncotarget2016749818628186927835910
   PubMedGoogle Scholar
• LiZZhouQLiYMean cerebral blood volume is an effective diagnostic index of recurrent and radiation injury in glioma patients: a meta-analysis of diagnostic testOncotarget201789156421565028152505
   PubMedGoogle Scholar
• ZhuangWJLiuCHSituHRClinical observation and evaluation of the combination of nimotuzumab with radiotherapy and cisplatin + 5FU in the treatment of elderly patients with nasopharyngeal carcinomaElderly Med Health Care2016225309312
   Google Scholar
• ZhouTZLiaoZWClinical study of nimotuzumab and three dimensional conformal radiotherapy in the treatment of recurrent nasopharyngeal carcinomaInter Med Health Guidance News2013192132573260
   Google Scholar
• YuHWZhuagYJYuFLiaoZWZhouTCClinical study of nimotuzumab combined with cisplatin and three-dimensional conformal radiotherapy in treatment of nasopharyngeal carcinomaGuangxi Med J2014367882884
   Google Scholar
• TangWBYangWCaoYEffect of nimotuzumab combined with radiotherapy and chemotherapy for locally advanced nasopharyngeal carcinomaGuangdong Med2012331116581662
   Google Scholar
• ShaoJFLiSPLianYNMaoJXMoYMClinical study of nimotuzumab plus nadaplatin combined with concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinomaModern Med J Chin2014412326
   Google Scholar
• LuHNiFCLiuLYWangQSiXYNimotuzumab concurrent radiotherapy and cisplatin chemotherapy in advanced nasopharyngeal carcinomaAntitumor Pharmacy201415053
   Google Scholar
• LouFYangPZhangRComparative study of nimotuzumab with radio-chemotherapy and radio-chemotherapy alone in the treatment of locally advanced nasopharyngeal carcinomaJ Clin Res2016335933935
   Google Scholar
• LiYLEffects of nimotuzumab with cisplatin and chemoradiotherapy for advanced nasopharyngeal carcinomaJ Med Forum2016364155156
   Google Scholar
• LiHMLiPQianYJA retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinomaBMC Cancer201616194627955638
   PubMedGoogle Scholar
• LiDBaiYXieKAoREfficacy and safety of nimotuzumab combined with nedaplatin and three-dimensional conformal concurrent radiotherapy for nasopharyngeal cancer chemotherapy and the impact of TGF-β1, S100A8 and S100A9J Med Res20154411136139
   Google Scholar
• HuJXGuWGHeZRLuoHTXuMShort-term effect of nimotuzumab combined with chemoradiotherapy for advanced nasopharyngeal carcinomaGuangdong Med J2013341320942096
   Google Scholar
• HeNSiYFSunYJEffect of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinomaGuangxi Med J2013357834837
   Google Scholar
• ChengJXunXLiGHClinical utility of nimotuzumab with cisplatin and chemoradiotherapy in advanced nasopharyngeal carcinomaHebei Med J2016222213215
   Google Scholar
• ChenYJQuanFWangLJLiHHClinical effect of nimotuzumab combined with cisplatin concurrent chemoradiotherapy in the treatment of advanced nasopharyngeal carcinomaChina Med Herald2016133118121
   Google Scholar
• WHOCancer country profiles 2014 Available from: http://who.int/cancer/country-profiles/en/Accessed March 7, 2017
   Google Scholar
• GondhowiardjoSMuthalibAKhotimahSRachmanANimotuzumab combined with radiotherapy reduces primary tumor and nodal volume in advanced undifferentiated nasopharyngeal carcinomaAsia Pac J Clin Oncol200953175180
   Google Scholar
• KameswaranMSamuelGDev SarmaHShindeSNDashAVenkateshM(131)I-Nimotuzumab – a potential radioimmunotherapeutic agent in treatment of tumors expressing EGFRAppl Radiat Isot20151029810226002276
   PubMedGoogle Scholar
• NabidAGangulyPVenkatesanVA phase I dose escalation study of a humanized monoclonal antibody to EGFR (hR3) in patients with locally advanced squamous cell cancer of the head and neck (SCCHN) treated with radiotherapyInt J Radiat Oncol Biol Phys2002542 Suppl288
   Google Scholar
• CrombetTNeningerECatalaMEpidermal growth factor based cancer vaccine for non-small cell lung cancer therapy: report from a phase I scale up trialEur J Cancer200238Suppl 7S137
   Google Scholar
• HuangXDYiJLGaoLMulti-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinomaZhonghua Zhong Liu Za Zhi2007293197201 Chinese17649636
   PubMedGoogle Scholar